CTC
ADNT icon

Central Trust Company’s Adient ADNT Stock Holding History

Central Trust Company’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$96 – 1562
2025
Q4 		$96 Buy
+5
New +$105 ﹤0.01% 1533
2024
Q3 		– Sell
-15
Closed -$371 – 1430
2024
Q2 		$371 Buy
15
+8
+114% +$227 ﹤0.01% 1377
2024
Q1 		$231 Hold
7
– – ﹤0.01% 1360
2023
Q4 		$255 Buy
+7
New +$240 ﹤0.01% 1365
2018
Q2 		– Sell
-147
Closed -$8K – 1249
2018
Q1 		$8K Sell
147
-50
-25% -$3.33K ﹤0.01% 1029
2017
Q4 		$16K Buy
197
+86
+77% +$6.94K ﹤0.01% 903
2017
Q3 		$9K Sell
111
-141
-56% -$10K ﹤0.01% 961
2017
Q2 		$17K Sell
252
-136
-35% -$9.25K ﹤0.01% 864
2017
Q1 		$28K Sell
388
-216
-36% -$14.2K ﹤0.01% 847
2016
Q4 		$35K Buy
+604
New +$31.9K ﹤0.01% 785

Other funds holding ADNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Central Trust Company's ADNT Position: Q1 2026 in Review

Central Trust Company sold out of Adient (ADNT) in Q1 2026, closing a stake of 5 shares — an estimated $96 sold.

Central Trust Company first reported a position in ADNT in Q4 2016 and held it in 10 quarters. The position peaked at $35K in Q4 2016. 290 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Central Trust Company reported no remaining Adient position as of Q1 2026 after selling out during the quarter.
  • Central Trust Company sold 5 Adient shares in Q1 2026, an estimated $96.
  • Central Trust Company first reported a position in Adient in Q4 2016 and held it in 10 quarters.
  • Central Trust Company's Adient position peaked at $35K in Q4 2016.
  • 290 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.